XML 34 R25.htm IDEA: XBRL DOCUMENT v3.22.2.2
Stock-Based Compensation (Tables)
 6 Months Ended
Jul. 30, 2022
Share-Based Payment Arrangement [Abstract]  
Schedule of Compensation Costs
The stock-based compensation costs that have been charged against income were as follows (in thousands):

13-Weeks Ended26-Weeks Ended
July 30,
2022		July 31,
2021		July 30,
2022		July 31,
2021
Stock-based compensation expense by type:
Stock options
$— $— $155 $174 
Restricted stock units1,488 1,092 3,613 2,880 
Employee stock purchases
77 24 235 108 
Director deferred compensation24 15 41 21 
  Total stock-based compensation expense1,589 1,131 4,044 3,183 
Income tax benefit recognized369 279 926 758 
  Stock-based compensation expense, net of income tax$1,220 $852 $3,118 $2,425 
Schedule of Equity Awards Granted
We granted the following equity awards:
13-Weeks Ended26-Weeks Ended
July 30,
2022		July 31,
2021		July 30,
2022		July 31,
2021
Stock options
— — 7,212 4,384 
Restricted stock unit awards
1,673 790 109,521 62,031 
Performance-based restricted stock unit awards
— — 49,978 22,492 
Deferred stock units
532 174 937 258 
Schedule of Shares Purchased
The number of shares purchased, the average price per share and the weighted-average grant date fair value of shares purchased through our employee stock purchase plan were as follows:
13-Weeks Ended26-Weeks Ended
July 30,
2022		July 31,
2021		July 30,
2022		July 31,
2021
Shares purchased7,352 2,063 21,625 9,508 
Average price per share$36.07 $58.56 $52.62 $43.44 
Weighted-average fair value at grant date$10.65 $11.39 $15.52 $11.44